Cardio Diagnostics Holdings Inc (CDIO) — Cash Flow Reinvestment Rate

Latest as of December 2020: 2.31x

Cardio Diagnostics Holdings Inc (CDIO) has a Cash Flow Reinvestment Rate of 2.31x as of December 2020, reinvesting $59.82K (capex $29.91K plus investments $-29.91K) from operating cash flow of $25.86K. Explore cash efficiency ratio of Cardio Diagnostics Holdings Inc to assess how effectively this company generates cash.

Reinvestment Rate

2.31x

(Capex + Investments) / Operating CF

Total Reinvested

$59.82K

Capex + Investments

Operating Cash Flow

$25.86K

USD

Capital Expenditures

$29.91K

USD

Cardio Diagnostics Holdings Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Cardio Diagnostics Holdings Inc across 1 annual periods. Explore how well can Cardio Diagnostics Holdings Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Cardio Diagnostics Holdings Inc (2020–2020)

Year-by-year capital reinvestment analysis for Cardio Diagnostics Holdings Inc. For live market cap and broader valuation context, see Cardio Diagnostics Holdings Inc stock valuation.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2020	2.31x	$59.82K	$25.86K	$29.91K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow